Fuller Laboratories develops both clinical and veterinary assays for the diagnosis of vector-borne and zoonotic diseases. For more than 2 decades, Fuller Laboratories has been an innovator in the development of infectious disease serology products, delivering unique formats in ever-increasing sophistication. Fuller Laboratories products offer the sensitivity, specificity and repeatability that reference laboratories demand.

Fuller Laboratories have particular expertise with vector-borne alpha- and gamma-proteobacteria, as well as some of the arboviruses, and have been working with these agents for over 30 years. The goal has always been to produce the optimal serological formats to differentiate true positives from true negatives for any specific agent, and to make these assays easily reproduced on a daily basis.

The product line, especially with the genus Rickettsia, requires the maintenance of a large collection of species in order to continue making the appropriate antigens available where needed. Our antigens differ from assay to assay and, with the exception of our recombinant antigens, they are purified from infected cell cultures propagated in our BSL-2+ and BSL-3 facilities.

 

Fuller Laboratories Sales Enquiries

Call Banksia on 1300 769 944, +617 3902 3000, email or complete the below form.